{"id":"W4410822970","doi":"10.1200/jco.2025.43.16_suppl.e19049","title":"Matching-adjusted indirect comparison (MAIC) of lisocabtagene maraleucel (liso-cel) versus axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) for treatment of third-line or later (3L+) R/R follicular lymphoma (FL): Update with 24 months of liso-cel follow-up (FU).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Follicular lymphoma; Internal medicine; Second line; Oncology; Lymphoma; First line","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01088994,0.001280948,0.002404454,0.000773689,0.0002352661,0.0009320497,0.001043433,0.001142904,0.007289133],"category_scores_gemma":[0.02102494,0.0003733202,0.008645841,0.0005773555,0.0004664902,0.0009752436,0.0008799252,0.002531701,0.0005653457],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008000241,"about_ca_system_score_gemma":0.0006763786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001625941,"about_ca_topic_score_gemma":0.002689122,"domain_scores_codex":[0.9887626,0.008419377,0.0007167914,0.001076467,0.0006937775,0.0003311041],"domain_scores_gemma":[0.9930698,0.004471004,0.001146617,0.0008167838,0.0002918699,0.0002038984],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.6619757,0.0008222847,0.02444341,0.008216571,0.217647,0.0001664814,0.0002116292,0.002811938,0.002537199,0.002958809,0.006672904,0.071536],"study_design_scores_gemma":[0.3552504,0.09999049,0.1095946,0.001868782,0.3657116,0.0006010841,0.0002956513,0.01521463,0.006880671,0.00809638,0.0362759,0.0002198171],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8670232,0.07004241,0.01965477,0.002012461,0.004258057,0.006177683,0.01601696,0.0004507112,0.01436386],"genre_scores_gemma":[0.9833471,0.001706324,0.006194556,0.001241296,0.0003542256,0.002353948,0.002320923,0.00004809266,0.002433468],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01088994,"threshold_uncertainty_score":0.05759215,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.147891444997853,"score_gpt":0.4464841575960615,"score_spread":0.2985927125982085,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}